Triple-H Therapy Benefit Calculator for SAH Vasospasm

Assess expected benefit from hypertension, hypervolemia, hemodilution for SAH-related vasospasm. Current evidence favors euvolemia + induced hypertension.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assess expected benefit from hypertension, hypervolemia, hemodilution for SAH-related vasospasm. Current evidence favors euvolemia + induced hypertension

Each component has a specific meaning:

  • Hypertension — The hypertension recorded for the scenario being assessed.
  • Hypervolemia — The hypervolemia recorded for the scenario being assessed.
  • Hemodilution — The hemodilution recorded for the scenario being assessed.

Note: Interpret the triple-h sah result against the thresholds and context described above.

How to Use

Enter the hypertension, hypervolemia, hemodilution for the scenario you are assessing. Assess expected benefit from hypertension, hypervolemia, hemodilution for SAH-related vasospasm. Current evidence favors euvolemia + induced hypertension. Use the triple-h sah result to inform your calculation.

Frequently Asked Questions